RAPTOR PHARMACEUTICAL CORP's ticker is and the CUSIP is 75382F956. A total of 4 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,000 | -88.9% | 573 | +467.3% | 0.00% | -100.0% |
| Q2 2016 | $18,000 | -30.8% | 101 | +46.4% | 0.00% | -50.0% |
| Q1 2016 | $26,000 | -63.4% | 69 | -38.4% | 0.00% | -66.7% |
| Q4 2015 | $71,000 | -62.6% | 112 | -80.0% | 0.01% | -57.1% |
| Q3 2015 | $190,000 | +280.0% | 559 | -10.1% | 0.01% | +250.0% |
| Q2 2015 | $50,000 | -7.4% | 622 | +72.8% | 0.00% | -33.3% |
| Q1 2015 | $54,000 | -28.9% | 360 | -42.5% | 0.01% | -33.3% |
| Q4 2014 | $76,000 | – | 626 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 672,100 | $6,445,000 | 0.10% |
| Citadel Advisors | 9,700 | $93,000 | 0.00% |